Inotropic function of myocardium in patients with persistent form of atrial fibrillation receiving antiarrhythmic drugs class Ic

Medicine and Dentistry

• Inpatient 100%
• Atrial Fibrillation 100%
• Patient 100%
• Myocardium 100%
• Antiarrhythmic Agent 100%
• Hospital 40%
• Propafenone 40%
• Amiodarone 40%
• Beta Adrenergic Receptor Blocking Agent 40%
• Prognosis 20%
• Symptom 20%
• Recurrent Disease 20%
• Blood 20%
• Chemotherapeutic Agent 20%
• Drug 20%
• Brain Natriuretic Peptide 20%
• Rest 20%
• Medication 20%
• Recurrence Risk 20%
• Echocardiography 20%
• Cardioversion 20%
• Electrocardiogram 20%
• Holter Monitoring 20%
• Sinus Rhythm 20%
• Exercise Test 20%
• Bisoprolol 20%

Nursing and Health Professions

• Atrial Fibrillation 100%
• Antiarrhythmic Agent 100%
• Propafenone 40%
• Beta Adrenergic Receptor Blocking Agent 40%
• Amiodarone 40%
• Electrocardiogram 40%
• Parameters 20%
• University Hospital 20%
• Symptom 20%
• Drug 20%
• Hospital 20%
• Exercise Test 20%
• Drug Therapy 20%
• Velocity 20%
• Recurrence Risk 20%
• Prognosis 20%
• Sinus Rhythm 20%
• Cardioversion 20%
• Recurrent Disease 20%
• Blood Cell Count 20%
• Brain Natriuretic Peptide 20%
• Bisoprolol 20%
• Echocardiography 20%
• Holter Monitoring 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Atrial Fibrillation 100%
• Antiarrhythmic Agent 100%
• Beta Adrenergic Receptor Blocking Agent 50%
• Propafenone 50%
• Amiodarone 50%
• Drug 25%
• Recurrent Disease 25%
• Symptom 25%
• Brain Natriuretic Peptide 25%
• Prognosis 25%
• Recurrence Risk 25%
• Prospective Study 25%
• Bisoprolol 25%